Miriam T. Rademaker
Christchurch, CAN, New Zealand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
Journal: Circulation. Heart failure
Published: November 19, 2009
Hemodynamic, hormonal, and renal actions of adrenomedullin 2 in experimental heart failure.
Journal: Circulation. Heart failure
Published: July 01, 2008
Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure.
Journal: Clinical science (London, England : 1979)
Published: December 07, 2007
Urocortin 1 administration from onset of rapid left ventricular pacing represses progression to overt heart failure.
Journal: American journal of physiology. Heart and circulatory physiology
Published: May 29, 2007
Urocortin 3: haemodynamic, hormonal, and renal effects in experimental heart failure.
Journal: European heart journal
Published: July 11, 2006
Integrated hemodynamic, hormonal, and renal actions of urocortin 2 in normal and paced sheep: beneficial effects in heart failure.
Journal: Circulation
Published: December 07, 2005
Four-day urocortin-I administration has sustained beneficial haemodynamic, hormonal, and renal effects in experimental heart failure.
Journal: European heart journal
Published: June 18, 2005
Cardiac natriuretic peptides for cardiac health.
Journal: Clinical science (London, England : 1979)
Published: October 13, 2004
Combined inhibition of angiotensin II and endothelin suppresses the brain natriuretic peptide response to developing heart failure.
Journal: Clinical science (London, England : 1979)
Published: November 07, 2003
Long-term adrenomedullin administration in experimental heart failure.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: November 02, 2002
Last Updated: 09/26/2026